Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. (OTCPK:FRTD) for $3 million in stock on May 18, 2014. The buyer will exchange each share of Fortitude with its share at consideration of $0.12 per share. The letter of intent includes a 10 day due diligence period with an estimated closing date for the transaction of May 30, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2021 | Analysis: Chasing yield, U.S. private equity firms nudge up risk on insurers | RE |
2021 | Chasing yield, U.S. private equity firms nudge up risk on insurers | RE |
1st Jan change | Capi. | |
---|---|---|
-.--% | 737 | |
-7.42% | 112B | |
-7.01% | 84.95B | |
+16.30% | 61.67B | |
+6.06% | 60.84B | |
+8.47% | 42.24B | |
+8.85% | 41.01B | |
+17.51% | 34.74B | |
+2.42% | 24.47B | |
-5.62% | 21.86B |
- Stock Market
- Equities
- FRTD Stock
- News Fortitude Group, Inc.
- Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. for $3 million.